/ /

ModernMedicine Resource Center More Topics
 

Advances in moderate-to-severe Atopic Dermatitis

New therapeutic optionLong-term data for dupilumab in atopic dermatitis revealed at the American Academy of Dermatology (AAD) 75th Annual Meeting reflect safety, rapid relief of troublesome symptoms and a long-lived response in keeping with the drug’s breakthrough status, experts told Dermatology Times.
Center’s goal: Give skin disease researchers all they needA new research center makes a database of five million human pathology specimens and 22,000 living consented patients, all searchable by diagnoses, as well as cutting edge human analytic techniques available to anyone interested in carrying out translational skin disease research on human cells and tissues.
Literature updates in pediatric dermatologyA recent pediatric allergy study spells out how to safely introduce peanuts to high-risk (and other) children. Another study suggests that melatonin may have immunomodulatory effects in AD.
Novel immunomodulators expected to usher in new therapeutic eraA number of systemic and topical treatments for atopic dermatitis are being developed that feature novel mechanisms of action targeting the inflammatory axes involved in the disease.
Phase 3 results demonstrate dupilumab efficacyNew data suggests positive safety and efficacy profile. Further studies need to assess long-term use.
Study offers new insight into pediatric eczema
Study offers new insight into pediatric eczemaResearchers have identified the skin phenotype of pediatric atopic dermatitis (AD) — a finding that challenges the notion of filaggrin's central role in the disease.
Crowdsourcing pinpoints unmet needs in eczema researchA new study using crowdsourcing harnesses the power of social media chatter to better understand unmet needs in eczema research.
Appreciating the role of microbial communities on the skinMicrobial colonization in the development of inflammatory conditions and immune-mediated conditions is a hot research topic, and new dermatologic therapies can potentially result from greater understanding of the role of microbial communities on the skin and in the gut.
Survey puts spotlight on a big problem for children with eczema: BullyingMany children with eczema suffer from bullying because of the skin condition. A new survey reflects what children and caregivers are experiencing, beyond the itch.
MMF relatively safe for off-label use in children, adults with severe ADFor patients with severe AD, treatment with the systemic immunomodulator methotrexate mycophenolate mofetil is a viable option, according to a recent review of the drug.